Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Histogen Inc (HSTO)

Histogen Inc (HSTO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Histogen: Q3 Earnings Snapshot

Histogen: Q3 Earnings Snapshot

HSTO : 0.2150 (unch)
Histogen: Q1 Earnings Snapshot

Histogen: Q1 Earnings Snapshot

HSTO : 0.2150 (unch)
Amerimmune LLC Maintains Intellectual Property on the COVID-19 Related Use of Caspase Inhibitors as a Result of Histogen Inc. Led Arbitration

Amerimmune LLC is a translational medicine biotechnology firm focused on discovery and rapid development of novel therapies for diseases, including COVID-19.

HSTO : 0.2150 (unch)
Histogen: Q3 Earnings Snapshot

Histogen: Q3 Earnings Snapshot

HSTO : 0.2150 (unch)
CEL-SCI Appoints Dr. Gail Naughton to Its Board of Directors

CEL-SCI Corporation (NYSE American: CVM) today announced the appointment of Dr. Gail K. Naughton to its Board of Directors.

CVM : 0.7299 (-4.60%)
ATIS : 0.1000 (-47.37%)
HSTO : 0.2150 (unch)
TXMD : 1.1100 (+1.83%)
Histogen Announces Closing of $5 Million Private Placement Priced At-the-Market Under Nasdaq Rules

SAN DIEGO, July 14, 2022 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing both restorative...

HSTO : 0.2150 (unch)
Histogen Announces $5 Million Private Placement Priced At-the-Market Under Nasdaq Rules

SAN DIEGO, July 12, 2022 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing both restorative...

HSTO : 0.2150 (unch)
Histogen Announces 1-for-20 Reverse Stock Split

SAN DIEGO, June 01, 2022 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing both restorative...

HSTO : 0.2150 (unch)
Histogen to Present at the H.C. Wainwright Global Investment Conference

SAN DIEGO, May 17, 2022 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing both restorative...

HSTO : 0.2150 (unch)
Paracrine Announces Appointment of Biotech Veteran David Crean, Ph.D. to the Board of Directors

Paracrine, Inc., a company developing its novel cell therapy platform in late-stage clinical trials in advanced wound care, announced today the appointment of David Crean, Ph.D. as an independent Director...

HSTO : 0.2150 (unch)

Barchart Exclusives

Oracle Stock Is Off Its Highs and Could Be Cheap Here
Oracle Corp. produced higher revenue in Q2 but lower free cash flow and FCF margins. However, ORCL stock is now off its highs and could be undervalued here. Shorting out-of-the-money puts is one way to play it. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar